A Natural Healthcare Company Pharmanex, Inc. Selected by Nature... Proven by Science.

Slides:



Advertisements
Similar presentations
Reversing Atherosclerosis with Aggressive Lipid Lowering Reversing Atherosclerosis with Aggressive Lipid Lowering Presented at American Heart Association.
Advertisements

Product Training Series
Agents Used in the Treatment of Hyperlipidemia
Monascus rice powder co-supplemented with coenzyme Q 10 improves serum lipids and LDL-lag time on hypercholesterolemia subjects. Shih-Wen Hsu 1#, Yi-Ting.
Robert K Huff PharmD. Candidate May Objectives The study was designed to examine 3 main aspects Biochemical effects Safety Tolerability Evacetrapib.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
MANAGING HIGH CHOLESTEROL
Understanding blood lipids and glucose How a Healthy Lifestyle can improve your numbers Susan Fullmer, PhD RD Associate Teaching Professor Nutrition, Dietetics,
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Simvastatin Increases HDL-C and Apolipoprotein A-1 Levels Significantly More Than Atorvastatin John P. Kastelein, Evan A. Stein, Michael A. Davidson, John.
By Elise LEfteriou  Red Yeast rice is a product of the Monascus purpureus, grown on rice.  It is a dietary staple in some Asian countries.  This certain.
Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
Metabolic Syndrome. America’s Health Status one-third of U.S. adults (35.7%) are obese. 17% (12.5 million) of children 2—19 years are obese. Top leading.
Downloaded from Slide 1 Ezetimibe Coadministered with Atorvastatin in Patients with Hypercholesterolemia and Coronary Heart.
New Cholestin, Overview New & Improved Cholestin: Red yeast rice-free formula Equally safe and effective as RYR* Contains novel ingredient extracted from.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
Hyperlipidemia John Baer.
Department of Family & Community Medicine
Familial hypercholesterolemia is a disorder of high LDL ("bad") cholesterol that is passed down through families, which means it is inherited. The condition.
Nutrition and Cardiovascular Disease. Cardiovascular Disease Includes heart attack, stroke Includes heart attack, stroke Leading cause of death in the.
Cholesterol is among the lipids (fats) in the bloodstream. Source: Supplied from diet or synthesized by liver. Importance: 1.Form cell membranes and.
Nutrition & Heart Disease Key Concepts and Facts Heart disease is leading cause of death Dietary and lifestyle factors are important Diets that provide.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Cholesterol Counts What you should know about your cholesterol.
SWBAT: Describe the structure of steroids Chapter 15 Cholesterol & Steroid Hormones.
Cholesterol and Triglycerides. What are triglycerides? Type of lipid found in your blood Store unused calories in your fat cells Hormones release triglycerides.
Prepared by: ABDULAZIZ ALESSA ABDULAZIZ ALESSA
Slide 1 Downloaded from Ezetimibe Factorial Coadministration Studies.
Copyright® Raisio A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Rimonabant in Obesity Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Jean-Pierre Despres RIO LIPIDS Trial.
© 2003, Wellsource Inc. Effect of Ketogenic Diet on Lipid Levels (shown is LDL-C) In this group of 141 children followed for 6 months, a ketogenic diet.
A randomized, double-blinded, placebo-controlled study of the effect of a combination of lemon verbena extract and fish oil omega-3 fatty acid on joint.
Case 15 Andrea De Mesa. Patient history A 44 y/o male, single, undergoes cardiovascular screening on advice of his attending physician. He is a smoker.
Cholesterol. What is cholesterol? Waxy, fat-like substance found in all cells. Dietary cholesterol – found only in animal-based foods Blood cholesterol.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 2 ARBITER-2 Trial Presented at The American Heart Association Scientific.
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
Better Health. No Hassles. HIGH BLOOD CHOLESTEROL Cholesterol is found in every cell in our body. Cholesterol is used to build healthy cells, as well as.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
LAB (6): LIPIDS PROFILE KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2013.
Lab 6 TC, LDL-C, HDL-C, and TG T.A. Bahiya Osrah
Controlling Your Blood Cholesterol and Triglycerides University of Georgia Cooperative Extension Service.
Lipid profiles in Cardio Vascular Diseases. What is a lipid profile? The lipid profile is a group of tests that are often ordered together to determine.
Cholesterol-lowering effects of a stanol- ester containing low-fat margarine used in conjunction with a strict lipid-lowering diet Andersson A et al. Eur.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Clinical Trial Results. org ILLUSTRATE Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. Steven E.
1 A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia Diabetes Care 28:1547–1554,
Lab (6): Lipids profile KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2012 T.A Nouf Alshareef
Statins The AURORA Trial Reference Fellstrom BC. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360. A.
LOW CARB, HIGH FAT ECON 4 LIN THOMPSON. KETOGENIC DIETS < 100 CARBOHYDRATES PER DAY ADKINS IS THE BEST KNOWN KETOGENIC DIET PUTS THE BODY IN KETOSIS.
Cholesterol-Lowering Ability of a Phytostanol Softgel Supplement in Adults with Mild to Moderate Hypercholesterolemia Woodgate D et al. Lipids. 2006;41:
Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.
Dr. Syed Waleem Pasha Assistant Professor Yenepoya Medical College
Classification of total cholesterol levels
FATS- Familial Atherosclerosis Treatment Study
Case 1: A 73-year-old white female with carotid disease
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Section 7: Aggressive vs moderate approach to lipid lowering
OmniHeart Feeding Study
Major classes of drugs to reduce lipids
VK2809 in NAFLD: a phase 2 study
PROSPER: trial design                                                                                                                                                                 
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
National Cholesterol Education Month
Section 6: Update on lipid treatment guidelines
Presentation transcript:

A Natural Healthcare Company Pharmanex, Inc. Selected by Nature... Proven by Science

Cholestin n History as a food n Manufacture n Science behind Cholestin u China u U.S.

Red Yeast Rice (Monascus purpureus Went) n Food supplement in China n Spice for the preparation of fish, meat, and bean curd n Rice wine n Traditional Chinese Medicine for blood circulation and digestion n Cholestin = Rice fermented with red yeast

Red Yeast Rice Preparation (circa 17th century)

History of Cholestin n 20th Century u Introduced in the US n 1970s u Link between cholesterol and heart disease u Discovery of cholesterol lowering properties by Japanese professor n 1990s u Development by Chinese company as an alternative to costly drugs u Licensed by Pharmanex to market as dietary supplement

China: 17 clinical studies Cholestin: Clinical Proof for Lowering Cholesterol n UCLA study u Placebo, double- blind design u 83 patients n Average cholesterol decrease of 16% n U.S. multi-center study u Open-label, wash-out design u 187 patients n Average cholesterol decrease of 15.5% Exclusive Red yeast rice -over 10 year research All natural fermentation Standardized U.S.

0 (weeks) 8 Age: years Total cholesterol: > 200 mg/dL Triglycerides: mg/dL Inclusion Criteria: Placebo (n=35) Red yeast rice extract (n=35,1.2 g/day) Randomized Study presented at AHA

Patients’ Profile Treatment groupPlacebo group Number of patients 35 Sex 22 M, 13 F Age (years) 62.7 ± ± 5.0 Age range (years) Disease history (years) Associated with coronary heart disease 57 Associated with hypertension 13 Associated with vascular diseases 33 American Heart Association, Orlando Florida, March 26, 1999

Red yeast rice extract (weeks) placebo (mg/dL) -17.4% p= % p=0.001 Changes in Total Cholesterol

(mg/dL) Red yeast rice extract placebo 048 (weeks) -17.6% p< % p<0.001 Changes in LDL Cholesterol

(mg/dL) Red yeast rice extract placebo 048 (weeks) -23.0% p= % p=0.037 Changes in Triglycerides

Placebo/diet 12 week treatment phase Week 8Week 9 Week 11 Week 12 Randomization 1 week Treatment arm Placebo arm Combined analysis UCLA Cholestin study in patients with Elevated cholesterol

Treatment groupPlacebo group PrePostPrePost Total cholesterol 250±30210±31*255±29250±36 Triglycerides 133±48124±44*143±46146±47 LDL cholesterol 173±27134±27*180±30175±33 HDL cholesterol 50±1350±1446±1046±11 *, p<0.05, compared to baseline. Values are means ± S.D., mg/dL UCLA Study: Data Summary

nPre-treatmentpost 12-week treatment ALT(IU/L)42 22 ± 920 ± 8 AST(IU/L)42 24 ± 523 ± 6 BUN(mg/dL)42 16 ± 415 ± 4  -GTP (IU/L)42 27 ± 1823 ± 19 LDH(IU/L) ± ± 23 UCLA Study: Liver and Kidney functions

* American Heart Association Step 1 diet alone Total cholesterol: mg/dL LDL-cholesterol: mg/dL Subjects: weeks Cholestin (2.4 g/day) Diet* Multi-center Study Presented at AHA

(mg/dL) Total Cholesterol LDL Cholesterol -21.7% -19.5% -15.5% -13.6% Diet + CholestinDiet (weeks) Cholesterol data

(weeks) Diet + Cholestin  Diet (mg/dL) All patients Patients with baseline TG >200 mg/dL -21.9% -15.7% -4.1% -3.8% Diet Triglyceride data

Patients with baseline HDL Male <40 mg/dL Female <45 mg/dL All patients (weeks) Diet + Cholestin Diet (mg/dL) +13.6% p< % p<0.01 HDL data

Multi-center study: Summary n Total cholesterol decreased by 15.5% n LDL-cholesterol decreased by 21.7% n HDL-cholesterol increased by 13.6% * n Triglycerides decreased by 21.9% ** * Males with baseline HDL-c  40 mg/dL or females with  45 mg/dL ** Patients with baseline triglycerides >200 mg/dL

How does Cholestin work? Fatty foods Acetyl-CoA HMG-CoA Cholesterol Other body fats HMG-CoA reductase enzyme Cholestin

Conclusion n Cholestin is a natural dietary supplement n Safe and highly effective in maintaining normal blood lipids n Effective if taken regularly